Eric Ahrens
Seminars
Thursday 23rd July 2026
Using Quantitative Molecular Imaging to Strengthen Preclinical Radiopharmaceutical Development
1:30 pm
- Applying advanced imaging technologies to evaluate target expression, pharmacokinetics and treatment response
- Developing imaging biomarkers that improve confidence in preclinical efficacy and safety assessment
- Generating robust translational evidence to support progression into early clinical development
